Acevedo J, Siegel JA (2022) Neurobiological, behavioral, and cognitive effects of ketamine in adolescents: a review of human and pre-clinical research. Behav Brain Res 435:114049

Article  CAS  PubMed  Google Scholar 

Agrawal S, Reyazuddin M, Singh S, Srivastava V, Andrade C (2025) Intramuscular ketamine for severe depression and suicidality in a 6-year-old child with congenital tracheoesophageal fistula. Asian J Psychiatr 108:104507

Article  PubMed  Google Scholar 

Annetta MG, Iemma D, Garisto C, Tafani C, Proietti R (2005) Ketamine: new indications for an old drug. Curr Drug Targets 6:789–794

Article  CAS  PubMed  Google Scholar 

Baghai TC, Blier P, Baldwin DS, Bauer M, Goodwin GM, Fountoulakis KN, Kasper S, Leonard BE, Malt UF, Stein D, Versiani M, Moller HJ, Section of Pharmacopsychiatry WPA (2011) General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of pharmacopsychiatry. Eur Arch Psychiatry Clin Neurosci 261(Suppl 3):207–245

Article  PubMed  Google Scholar 

Baghai TC, Blier P, Baldwin DS, Bauer M, Goodwin GM, Fountoulakis KN, Kasper S, Leonard BE, Malt UF, Stein DJ, Versiani M, Moller HJ (2012) Executive summary of the report by the WPA section on pharmacopsychiatry on general and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders. Eur Arch Psychiatry Clin Neurosci 262:13–22

Article  PubMed  Google Scholar 

Bergman SA (1999) Ketamine: review of its pharmacology and its use in pediatric anesthesia. Anesth Prog 46:10–20

CAS  PubMed  PubMed Central  Google Scholar 

Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, Krystal JH (2000) Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 47:351–354

Article  CAS  PubMed  Google Scholar 

Bruton AM, Wesemann DG, Machingo TA, Majak G, Johnstone JM, Marshall RD (2025) Ketamine for mood disorders, anxiety, and suicidality in children and adolescents: a systematic review. Eur Child Adolesc Psychiatry 34:141–157

Article  PubMed  Google Scholar 

Canuso CM, Singh JB, Fedgchin M, Alphs L, Lane R, Lim P, Pinter C, Hough D, Sanacora G, Manji H, Drevets WC (2018) Efficacy and safety of intranasal Esketamine for the rapid reduction of symptoms of depression and suicidality in patients at imminent risk for suicide: results of a double-blind, randomized, placebo-controlled study. Am J Psychiatry 175:620–630

Article  PubMed  Google Scholar 

Chen X, Hou X, Bai D, Lane R, Zhang C, Canuso C, Wang G, Fu DJ (2023) Efficacy and safety of flexibly dosed Esketamine nasal spray plus a newly initiated oral antidepressant in adult patients with Treatment-Resistant depression: A Randomized, Double-Blind, Multicenter, Active-Controlled study conducted in China and USA. Neuropsychiatr Dis Treat 19:693–707

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cullen KR, Amatya P, Roback MG, Albott CS, Westlund Schreiner M, Ren Y, Eberly LE, Carstedt P, Samikoglu A, Gunlicks-Stoessel M, Reigstad K, Horek N, Tye S, Lim KO, Klimes-Dougan B (2018) Intravenous ketamine for adolescents with treatment-resistant depression: an open-label study. J Child Adolesc Psychopharmacol 28:437–444

Article  CAS  PubMed  PubMed Central  Google Scholar 

Daly EJ, Singh JB, Fedgchin M, Cooper K, Lim P, Shelton RC, Thase ME, Winokur A, Van Nueten L, Manji H, Drevets WC (2018) Efficacy and safety of intranasal Esketamine adjunctive to oral antidepressant therapy in treatment-resistant depression: a randomized clinical trial. JAMA Psychiatr 75:139–148

Article  Google Scholar 

Di Vincenzo JD, Siegel A, Lipsitz O, Ho R, Teopiz KM, Ng J, Lui LMW, Lin K, Cao B, Rodrigues NB, Gill H, McIntyre RS, Rosenblat JD (2021) The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: a systematic review. J Psychiatr Res 137:232–241

Article  PubMed  Google Scholar 

Dolansky G, Shah A, Mosdossy G, Rieder MJP, health c (2008) What is the evidence for the safety and efficacy of using. Ketamine children? 13:307–308

CAS  Google Scholar 

Domino EF (2010) Taming the ketamine tiger. 1965. Anesthesiol. 113:678–684

Dong C, Anand KJ (2013) Developmental neurotoxicity of ketamine in pediatric clinical use. Toxicol Lett 220:53–60

Article  CAS  PubMed  Google Scholar 

Dwyer JB, Beyer C, Wilkinson ST, Ostroff RB, Qayyum Z, Bloch MH (2017) Ketamine as a treatment for adolescent depression: a case report. J Am Acad Child Adolesc Psychiatry 56:352–354

Article  PubMed  Google Scholar 

Dwyer JB, Stringaris A, Brent DA, Bloch MH (2020) Annual research review: defining and treating pediatric treatment-resistant depression. J Child Psychol Psychiatry 61:312–332

Article  PubMed  PubMed Central  Google Scholar 

Dwyer JB, Landeros-Weisenberger A, Johnson JA, Londono Tobon A, Flores JM, Nasir M, Couloures K, Sanacora G, Bloch MH (2021) Efficacy of intravenous ketamine in adolescent treatment-resistant depression: a randomized midazolam-controlled trial. Am J Psychiatry 178:352–362

Article  PubMed  Google Scholar 

Easterly CW, Taylor R (2023) Ketamine augmentation of electroconvulsive therapy in an adolescent patient with suicidal ideation, disordered eating, and type 1 diabetes mellitus: a case report. J ECT 39:63–64

Article  PubMed  Google Scholar 

Faria-Guimaraes D, Vieira F, Souza-Marques B, Silva SS, Bandeira ID, Souza LS, Alves-Pereira R, Fontes M, Mello RP, Leal GC, Cardoso TA, Kapczinski F, Lacerda ALT, Sampaio AS, Quarantini LC (2022) Letter to the editor: antidepressant and antisuicidal effects of Esketamine in adolescents with major depressive disorder and suicidal ideation: a case series. J Child Adolesc Psychopharmacol 32:366–367

Article  PubMed  Google Scholar 

Faries E, Mabe LA, Franzen RL, Murtaza S, Nathani K, Ahmed B, Prokop L, Mohammed K, Ahmed AT (2024) Interventional approaches to treatment resistant depression (DTR) in children and adolescents: A systematic review and meta-analysis. J Affect Disord 367:519–529

Article  CAS  PubMed  Google Scholar 

Fedgchin M, Trivedi M, Daly EJ, Melkote R, Lane R, Lim P, Vitagliano D, Blier P, Fava M, Liebowitz M, Ravindran A, Gaillard R, Ameele HVD, Preskorn S, Manji H, Hough D, Drevets WC, Singh JB (2019) Efficacy and safety of fixed-dose Esketamine nasal spray combined with a new oral antidepressant in treatment-resistant depression: results of a randomized, double-blind, active-controlled study (TRANSFORM-1). Int J Neuropsychopharmacol 22:616–630

Article  PubMed  PubMed Central  Google Scholar 

Fountoulakis KN, Gonda X (2019) Modeling human temperament and character on the basis of combined theoretical approaches. Ann Gen Psychiatry 18:21

Article  PubMed  PubMed Central  Google Scholar 

Fountoulakis KN, Gonda X (2022) Sex differences in maturation and aging of human personality on the basis of a recently developed complex hierarchical model of temperament and character. Int J Psychiatry Clin Pract 26:58–71

Article  PubMed  Google Scholar 

Fountoulakis KN, Saitis A, Schatzberg AF (2025) Esketamine treatment for depression in adults: a PRISMA systematic review and meta-analysis. Am J Psychiatry 182:259–275

Article  PubMed  Google Scholar 

Fu DJ, Ionescu DF, Li X, Lane R, Lim P, Sanacora G, Hough D, Manji H, Drevets WC, Canuso CM (2020) Esketamine nasal spray for rapid reduction of major depressive disorder symptoms in patients who have active suicidal ideation with intent: double-blind, randomized study (ASPIRE I). J Clin Psychiatry 81

Garcia-Carachure I, Lira O, Themann A, Rodriguez M, Flores-Ramirez FJ, Lobo MK, Iniguez SD (2024) Sex-specific alterations in spatial memory and hippocampal AKT-mTOR signaling in adult mice pre-exposed to ketamine and/or psychological stress during adolescence. Biological Psychiatry Global Open Science 4:240–251

Article  PubMed  Google Scholar 

Gerhard DM, Pothula S, Liu RJ, Wu M, Li XY, Girgenti MJ, Taylor SR, Duman CH, Delpire E, Picciotto M, Wohleb ES, Duman RS (2020) GABA interneurons are the cellular trigger for ketamine’s rapid antidepressant actions. J Clin Invest 130:1336–1349

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang X, Lin J, Demner-Fushman D (2006) Evaluation of PICO as a knowledge representation for clinical questions. AMIA Annu Symp Proc 2006:359–363

PubMed  PubMed Central  Google Scholar 

Ikonomidou C, Bosch F, Miksa M, Bittigau P, Vockler J, Dikranian K, Tenkova TI, Stefovska V, Turski L, Olney JW (1999) Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 283:70–74

Article  CAS  PubMed  Google Scholar 

Ionescu DF, Fu DJ, Qiu X, Lane R, Lim P, Kasper S, Hough D, Drevets WC, Manji H, Canuso CM (2021) Esketamine nasal spray for rapid reduction of depressive symptoms in patients with major depressive disorder who have active suicide ideation with intent: results of a phase 3, double-blind, randomized study (ASPIRE II). Int J Neuropsychopharmacol 24:22–31

Article  PubMed  Google Scholar